Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1

Experimental Physiology

Volumn 91, Issue 5, 2006, Pages 803-806

  Semenza, Gregg L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Broadway Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; OXYGEN; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR;

CELL NUCLEUS; CONFERENCE PAPER; GENE EXPRESSION; GENE LOCUS; HETEROZYGOTE; HOMEOSTASIS; HYDROXYLATION; HYPOXIA; MOUSE; NONHUMAN; NULL ALLELE; OXYGENATION; PATHOGENESIS; REGULATORY MECHANISM;

EID: 33747621613     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2006.033498     Document Type: Conference Paper

References (33)

1. Beck I, Ramirez S, Weinmann R & Caro J (1991). Enhancer element at the 3′-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene. J Biol Chem 266, 15563-15566.
2. Bruick RK & McKnight SL (2001). A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340.
3. Brunelle JK, Bell EL, Quesada NM, Vercauteren K, Tiranti V, Zeviani M et al. (2005). Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 1, 409-414.
4. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M et al. (1998). Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485-490.
5. Chilov D, Camenisch G, Kvietikova I, Ziegler U, Gassmann M & Wenger RH (1999). Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1α. J Cell Sci 112, 1203-1212.
6. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR et al. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
7. Guzy RD, Hoyos B, Robin E, Chen H, Liu L, Mansfield KD et al. (2005). Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1, 401-408.
8. Hewitson KS, McNeill LA & Schofield CJ (2004). Modulating the hypoxia-inducible factor signaling pathway. Curr Pharm Des 10, 821-833.
9. 2-dependent degradation domain via the ubiquitin-proteasome pathway. ProcNatl Acad Sci U S A 95, 7987-7992.
10. 2 sensing. Science 292, 464-468.
11. 2 homeostasis by hypoxia-inducible factor1α. Genes Dev 12, 149-162.
12. 2-regulated prolyl hydroxylation. Science 292, 468-472.
13. 2 tension. Am J Physiol 271, C1172-C1180.
14. Kallio PJ, Wilson WJ, O'Brien S, Makino Y & Poellinger L (1999). Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J Biol Chem 274, 6519-6525.
15. Kline DD, Peng Y, Manalo DJ, Semenza GL & Prabhakar NR (2002). Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. Proc Natl Acad Sci U S A 99, 821-826.
16. Kotch LE, Iyer NV, Laughner E & Semenza GL (1999). Defective vascularization of HIF-1α-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 209, 254-267.
17. Li J, Bosch-Marce M, Nanayakkara A, Savransky V, Fried SK et al. (2006). Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor 1α. Physiol Genomics 25, 450-457.
18. Mansfield KD, Guzy RD, Pan Y, Young RM, Cash TP et al. (2005). Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab 1, 393-399.
19. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME et al. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275.
20. Pugh CW, Tan CC, Jones RW & Ratcliffe PJ (1991). Functional analysis of an oxygen-regulated transcriptional enhancer lying 3′ to the mouse erythropoietin gene. Proc Natl Acad Sci U S A 88, 10553-10557.
21. Ryan HE, Lo J & Johnson RS (1998). HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J 17, 3005-3015.
22. Salceda S & Caro J (1997). Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272, 22642-22647.
23. Semenza GL (2006). Development of novel therapeutic strategies that target HIF-1. Expert Opin Ther Targets 10, 267-280.
24. Semenza GL, Nejfelt MK, Chi SM & Antonarakis SE (1991). Hypoxia-inducible nuclear factors bind to an enhancer located 3′ to the human erythropoietin gene. Proc Natl Acad Sci U S A 88, 5680-5684.
25. Semenza GL & Wang GL (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12, 5447-5454.
26. Shimoda LA, Manalo DJ, Sham JSK, Semenza GL & Sylvester JT (2001). Partial HIF-1α deficiency impairs pulmonary arterial myocyte electrophysiological responses to chronic hypoxia. Am J Physiol 281, L202-L208.
27. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW et al. (2000). The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157, 411-421.
28. 2 tension. Proc Natl Acad Sci U S A 92, 5510-5514.
29. Wang GL & Semenza GL (1995). Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270, 1230-1237.
30. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T et al. (1999). Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. J Clin Invest 103, 691-696.
31. Yu F, White SB, Zhao Q & Lee FS (2001). HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci U S A 98, 9630-9635.
32. Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW & Semenza GL (2000). Expression of hypoxia-inducible factor 1α in human brain tumors: association with angiogenesis, invasion, and progression. Cancer 88, 2606-2618.
33. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D et al. (1999). Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 59, 5830-5835.